Uses, Dosage & Side Effects: Rinvoq Tablet
Rinvoq Tablet
| Generic name | upadacitinib |
|---|---|
| Drug class | Janus kinase (JAK) inhibitor |
| Forms | Extended-release (prolonged-release) oral tablets (15 mg, 30 mg, 45 mg), Oral solution (1 mg/mL) |
Rinvoq is a prescription medicine that contains the active substance upadacitinib. It belongs to a group of medicines called Janus kinase inhibitors and is used to reduce inflammation in several long-term conditions.
Read the full guideUses, dosage, side effects, precautions, and sources, written from the same verified facts.
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Took too much, or feel seriously unwell? Get urgent medical help now.
Facts checked by a personFull disclaimer
